Novanta/$NOVT
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Novanta
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
Ticker
$NOVT
Sector
Digital Hardware
Primary listing
Employees
3,000
Headquarters
Website
Novanta Metrics
BasicAdvanced
$4.8B
91.45
$1.47
1.62
-
Price and volume
Market cap
$4.8B
Beta
1.62
52-week high
$149.95
52-week low
$98.27
Average daily volume
415K
Financial strength
Current ratio
3.685
Quick ratio
2.664
Long term debt to equity
19.308
Total debt to equity
23.034
Interest coverage (TTM)
5.41%
Profitability
EBITDA (TTM)
178.033
Gross margin (TTM)
44.39%
Net profit margin (TTM)
5.49%
Operating margin (TTM)
11.84%
Effective tax rate (TTM)
22.71%
Revenue per employee (TTM)
$330,000
Management effectiveness
Return on assets (TTM)
4.54%
Return on equity (TTM)
5.23%
Valuation
Price to earnings (TTM)
91.449
Price to revenue (TTM)
5.016
Price to book
3.65
Price to tangible book (TTM)
9.86
Price to free cash flow (TTM)
101.564
Free cash flow yield (TTM)
0.98%
Free cash flow per share (TTM)
1.324
Growth
Revenue change (TTM)
3.30%
Earnings per share change (TTM)
-16.95%
3-year revenue growth (CAGR)
4.43%
10-year revenue growth (CAGR)
10.13%
3-year earnings per share growth (CAGR)
-10.64%
10-year earnings per share growth (CAGR)
3.73%
What the Analysts think about Novanta
Analyst ratings (Buy, Hold, Sell) for Novanta stock.
Novanta Financial Performance
Revenues and expenses
Novanta Earnings Performance
Company profitability
Novanta News
AllArticlesVideos
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025
Business Wire·4 days ago
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 24, 2026
Business Wire·1 month ago
Novanta to Present at the CJS Securities 26th Annual New Ideas for the New Year Investor Conference on Wednesday, January 14, 2026
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Novanta stock?
Novanta (NOVT) has a market cap of $4.8B as of February 28, 2026.
What is the P/E ratio for Novanta stock?
The price to earnings (P/E) ratio for Novanta (NOVT) stock is 91.45 as of February 28, 2026.
Does Novanta stock pay dividends?
No, Novanta (NOVT) stock does not pay dividends to its shareholders as of February 28, 2026.
When is the next Novanta dividend payment date?
Novanta (NOVT) stock does not pay dividends to its shareholders.
What is the beta indicator for Novanta?
Novanta (NOVT) has a beta rating of 1.62. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.